Having trouble accessing articles? Reset your cache.

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 11/14 cls
Advanced Life (NASDAQ:ADLS) Susquehanna Angela Larson Price target Net positive -21% $0.23
Larson lowered her target to $2 from $2.50. She noted the company will have to find a partner for cethromycin or raise equity before January, as it is running low on cash, and said she has doubts as to whether a partner will be found for the U.S., Japan and Europe. Cethromycin, a ketolide antibiotic, is partnered with Wyeth (NYSE:WYE) in 24 Asia-Pacific countries and is under review in the U.S. for mild-to-moderate community-acquired pneumonia (CAP). Larson also questioned if the company would not be better off with fewer employees.
Alkermes (NASDAQ:ALKS)

Read the full 1334 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers